Abnormal expansion of segmented filamentous bacteria in the gut: A role in pathogenesis of chronic inflammatory intestinal diseases?

Reviews and Research in Medical Microbiology

Volumn 22, Issue 3, 2011, Pages 45-47

  Bellavia, Maurizio ^a   Damiano, Giuseppe ^a   Gioviale, Maria C ^a   Palumbo, Vincenzo D ^a   Cacciabaudo, Francesco ^a   Buscemi, Giuseppe ^a   Lo Monte, Attilio Ignazio ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

chronic inflammatory intestinal diseases; intestinal immune system; segmented filamentous bacteria; small intestinal bacterial overgrowth

Indexed keywords

ANEMIA; ARTICLE; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; CHRONIC DISEASE; CROHN DISEASE; DIARRHEA; ENTERITIS; HUMAN; IMMUNOCOMPETENT CELL; INTESTINE FLORA; IRRITABLE COLON; MALABSORPTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TH17 CELL; UPPER GASTROINTESTINAL TRACT; WEIGHT REDUCTION;

EID: 79960371715     PISSN: 0954139X     EISSN: 14735601     Source Type: Journal    
DOI: 10.1097/MRM.0b013e328348ce81     Document Type: Article

References (29)

1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007; 449:811-818. (Pubitemid 47598621)
2. Neish AS. Microbes in gastrointestinal health and disease. Gastroenterology 2009; 136:65-80.
3. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science 2005; 308:1635-1638. (Pubitemid 40807514)
4. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007; 5:e156.
5. Tomasello G, Bellavia M, Palumbo VD, Gioviale MC, Damiani P, Lo Monte AI. From gut microflora imbalance to mycobac-teria infection: is there a relationship with chronic intestinal inflammatory diseases? Ann Ital Chir 2011; 82.
6. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134:577-594. (Pubitemid 351173057)
7. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117:514-521. (Pubitemid 46348505)
8. Korn T, Oukka M, Kuchroo V, Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 2007; 19:362-371. (Pubitemid 351274046)
9. Liu Z, Yadav PK, Su J, Wang J, Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009; 15:5784-5788.
10. Ivanov II, Atarashi K, Manel N, Brodie EL, Shime T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009; 139:485-498.
11. Suzuki K, Meek B, Doi Y, Muramatsu M, Chiba T, Honjo T, Fagarasan S. Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proc Natl Acad Sci USA 2004; 101:1981-1986. (Pubitemid 38229001)
12. Fuentes S, Egert M, Jimenez-Valera M, Monteoliva-Sanchez M, Ruiz-Bravo A, Smidt H. A strain of Lactobacillus plantarum affects segmented filamentous bacteria in the intestine of immunosuppressed mice. FEMS Microbiol Ecol 2008; 63:65-72. (Pubitemid 350233292)
13. Reddymasu SC, Sostarich S, McCallum RW. Small intestinal bacterial overgrowth in irritable bowel syndrome: are there any predictors? BMC Gastroenterology 2010; 10:1-5.
14. Atarashi K, Tanoue T, Honda K. Induction of lamina propria Th17 cells by intestinal commensal bacteria. Vaccine 2010; 28:8036-8038.
15. Ohashi Y, Hiraguchi M, Sunaba C, Tanaka C, Fujisawa T, Ushida K. Colonization of segmented filamentous bacteria and its interaction with the luminal IgA level in conventional mice. Anaerobe 2010; 16:543-546.
16. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of IL-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140:957-965.
17. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136:1979-1988.
18. Frissora CL, Cash BD. Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 2007; 25:1271-1281. (Pubitemid 46763454)
19. Lettre G, Rioux JD. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008; 17:R116-R121.
20. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, et al. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann NY Acad Sci 2009; 1173:640-648.
21. Behr MA, Divangahi M, Lalande JD. What's in a name? The (mis)labelling of Crohn's as an autoimmune disease. Lancet 2010; 376:202-203.
22. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010; 32:815-827.
23. Engstrom JF, Arvanitakis C, Sagawa A, Abdou NI. Secretory immunoglobulin deficiency in a family with inflammatory bowel disease. Gastroenterology 1978; 74:747-751. (Pubitemid 8333147)
24. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-82.
25. Wehkamp J, Wang G, Kubler I. The Paneth cell adefensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol 2007; 179:3109-3118.
26. Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, et al. Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population. Dig Liver Dis 2008; 40:723-730.
27. Simren M, Stotzer PO. Use and abuse of hydrogen breath tests. Gut 2006; 55:297-303. (Pubitemid 43268261)
28. Di Stefano M, Miceli E, Missanelli A, Mazzocchi S, Corazza GR. Absorbable vs. nonabsorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment Pharmacol Ther 2005; 21:985-992. (Pubitemid 40529732)
29. Frank DN, Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of micro-bial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA 2007; 104:13780-14137.